Cite
HARVARD Citation
Clark, H. et al. (2003). The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Archives of disease in childhood. 88 (11), pp. 981-984. [Online].